News

trial study hybrid or heart valve repiar tct 2013 st. jude portico

St. Jude Medical Inc. announced positive results for the 23 and 25mm Portico Transcatheter Aortic Heart Valves in the Portico Transfemoral CE mark trial (Portico TF CE Trial)....

medtronic corevalve cath lab hybrid or heart valve repair study TCT 2013

The CoreValve U.S. pivotal trial showed very positive results for the Medtronic CoreValve system, comparable or better than data from the Sapien Partner Trial.

heart valve repair valve-in-valve melody transcatheter pulmonary houston

A new valve recently approved by the U.S. Food and Drug Administration (FDA) now gives heart patients a new way to manage their disease without having to undergo open ...

heart valve repair clinical trial study colibri tavi TCT

Colibri Heart Valve LLC, a medical device company, announced that patient enrollment has concluded in...

MitraClip, Abbott, transcatheter mitral valve repair, FDA approval

The U.S. Food and Drug Administration (FDA) has granted market clearance for the MitraClip, the first minimally invasive transcatheter device to repair mitral regurgitation (MR). The device is...

heart valve repair clinical trial study valtech cardio cardioband annuloplasty

Valtech Cardio Ltd., a medical device company that develops solutions for mitral valve repair and...

heart valve repair clinical trial study transcatheter aortic valve trinity

Transcatheter Technologies GmbH, a medical device company, announced the successful first-in-human implantation of its transapical Trinity aortic ...

heart valve repair medtronic corevalve evolut recapturable

Medtronic Inc. announced the first implants in the CoreValve Evolut R clinical study, which will evaluate the safety and effectiveness of the CoreValve Evolut R recapturable system. This recapture...

cardiovascular ultrasound structural heart valve repair hollywood presbyterian

A mother and her 25-week-old fetus are doing well after a team of physicians performed a successful in utero...

Sapien, TAVR, hybrid OR

As a cutting-edge technique, many hospitals around the country are investigating the development of their own TAVR programs. Starting a TAVR program requires a collaborative commitment to care and...

The Cardiovascular Research Foundation (CRF) announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2013...

CardioLogical Solutions announced that it has been issued two additional patents for its family of aortic embolic protection devices designed to prevent stroke and other ischemic complications....

JenaValve, TAVI system, heart valve repair, CE Mark, JenaValve CE Mark

JenaValve Technology, Inc. announced that it has raised $62.5 million in a Series C venture round.

aortic valve, Edwards Lifesciences, SAPIEN, SAPIEN aortic valve

Edwards announced a new post-hoc data analysis from The PARTNER Trial demonstrated that diabetic patients with aortic stenosis in need of heart valve replacement, but at high surgical risk,...

Lotus Valve System, heart valves, Boston Scientific Corporation

Boston Scientific reported favorable six-month results from the first 60 patients enrolled in the REPRISE II clinical trial evaluating the safety and performance of the Lotus Valve System in...

JenaValve, TAVI system, heart valve repair, CE Mark, JenaValve CE Mark

JenaValve Technology Inc. has received CE (Conformite Europeenne) mark approval from European regulators for its transapical TAVI system for the treatment of aortic insufficiency (AI), also known...

Edwards Lifesciences Medtronic Injunction Sapien XT Heart Valves Germany

The injunction against sales of Medtronic's transcatheter heart valves in Germany — issued in a July 12, 2013, court ruling — has gone into effect, according to Edwards Lifesciences Corp. The...

Vascular closure devices have a definite niche in areas where they were not originally intended but have found frequent off-label use because of their utility.

Direct Flow Medical Inc. announced the first patient enrollment in the U.S. SALUS clinical trial. The trial will study the Direct Flow Medical Transcatheter Aortic Heart Valve System,...

September 9, 2013 — Keystone Heart, a company in the development of cerebral protection devices for interventional cardiology and cardiac surgery procedures, announced its TriGuard cerebral...